Pharmafile Logo
Pharmafocus logo
Advanced Search

Measuring Return on Investment of Health Economics and Outcomes Research through the Cloud

July 2, 2012
Medical Communications HEOR, ROI, interactive tools, market access

Health economics and outcomes research (HEOR) is a young and fascinating area of research with an engaged academic community. Methodology …

Feature
Thought Leadership
ariad_slideshow-3

Ariad touts next generation CML treatment

June 29, 2012
Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland

Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …

News

McCann Torre Lazur wins Best of Health top prize

June 29, 2012
Medical Communications Best of Health awards, Euro RSCG Life UK, IPA, Langland, McCann Torre Lazur, Torre Lazur McCann, Woolley Pau

McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …

News

Quintiles offers lifeline to Merck Serono employees

June 28, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts, manufacturing

Quintiles has said it will make at least 100 job offers within the next three months to workers set to …

News

Albemarle expands API capacity at Michigan facility

June 28, 2012
Manufacturing and Production API, Albemarle, Michigan, manufacturing

Fine chemicals, polymers and catalysts specialist Albemarle has brought new manufacturing capacity for active pharmaceutical ingredients (APIs) online at its …

News

Growth in health spending ‘grinds to a halt’

June 28, 2012
Business Services, Sales and Marketing Financial, GDP, OECD, growth, pharma

Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term …

News

DH admits cancer awareness campaigns failed

June 28, 2012
Sales and Marketing Cancer, Department of Health, GPs, government

The government’s £9 million cancer awareness campaigns were built upon failed pilots, according to newly released data. The national awareness …

News

US judges vote to keep Obamacare

June 28, 2012
Sales and Marketing Health reform, President Obama, US

The US Supreme Court will allow President Obama’s health reforms to stand.The nine-member Supreme Court has decided not to repeal …

News
Yammer image

Microsoft buys Yammer for $1.2 billion

June 28, 2012
Medical Communications Daiichi Sankyo, Facebook, Microsoft, Yammer, social network

Microsoft has acquired Yammer, an internal social networking system for businesses, for $1.2 billion. Set up in 2008, Yammer closely …

News

MRN gets SMART with its clinical trial scheduling

June 28, 2012
Research and Development clinical trials, electronic data capture, medical research network, mrn, patient scheduling

Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial and site nurse support as well …

News
Press release

ZS Associates elects new managing director

June 28, 2012
Business Services, Medical Communications, Sales and Marketing Chris Wright, ZS Associates

Sales and marketing consulting firm ZS Associates announced today that Chris Wright has been elected by firm partners to the …

Appointment

Ireland agrees deal on medicines

June 28, 2012
Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing

Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …

News
Apps image

Apps not the way forward for trial recruitment

June 28, 2012
Medical Communications Pfizer, apps, digital, virtual trial

After Pfizer admitted defeat in the first ever ‘virtual trial’ earlier this year, it seems that we are not yet …

News
FDA image

FDA clears Arena and Eisai’s obesity drug

June 28, 2012
Sales and Marketing Arena, Belviq, Eisai, FDA, Qnexa, Roche, obesity

Eisai and Arena’s Belviq has gained FDA approval, making it the first obesity drug to be approved in over ten …

News

Astellas submits new prostate cancer drug to EMA

June 28, 2012
Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …

News
Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

News
ABPI image

ABPI to no longer ‘shy away’ from big issues

June 27, 2012
Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead

The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …

News
Tarceva image

NICE final yes for Zytiga and Tarceva

June 27, 2012
Sales and Marketing Janssen, NHS, NICE, NSCLC, Roche, Tarceva, Zytiga

In final guidance published today, NICE is recommending two new drugs for patients with prostate and lung cancer. Janssen’s Zytiga …

News

Amylin withheld safety data, says FDA

June 27, 2012
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …

News
CSL Behring

CSL Behring launches new dosing app

June 27, 2012
Medical Communications Beriplex P/N, CSL Behring, app, digital

Biotherapy firm CSL Behring UK has launched an app for doctors to aid the management of its anaesthetic treatment Beriplex …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026